Silence Therapeutics PLC
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| 524.8% | 524.8% | 23,856.3% | 23,856.3% | – | – | – | – | – | – | – | – | 2,071.3% | 2,071.3% | – | 888.2% | 117.3% | 61.0% | 48.9% | 67.6% | 65.0% | 59.8% | 39.8% | 64.6% | 71.0% | 81.0% | 39.9% | 31.1% | 57.4% | 64.1% | 17.8% | 441.1% | 242.9% | 6.6% | 38.0% | 37.9% | 40.3% | 35.3% | 27.7% | – | 49.0% | |
| -424.8% | -424.8% | -23,756.3% | -23,756.3% | – | – | – | – | – | – | – | – | -1,971.3% | -1,971.3% | 100.0% | 100.0% | -17.3% | 39.0% | 51.1% | 32.4% | 35.0% | 40.2% | 60.2% | 35.4% | 29.0% | 19.0% | 60.1% | 68.9% | 42.6% | 35.9% | 82.2% | -341.1% | -142.9% | 93.4% | 62.0% | 62.1% | 59.7% | 64.7% | 72.3% | – | 51.0% | |
| 524.8% | 524.8% | 23,856.3% | 23,856.3% | – | – | – | – | – | – | – | – | 3,394.3% | 3,394.3% | 888.2% | 888.2% | 174.4% | 441.9% | 237.2% | 302.4% | 250.8% | 211.6% | 132.9% | 297.3% | 260.2% | 176.3% | 110.2% | 138.6% | 319.3% | 473.4% | 75.5% | 1,838.6% | 1,340.2% | 83.9% | 14,657.1% | 7,878.1% | 12,920.8% | 25,732.4% | 1,980.8% | – | 7,480.2% | |
| 249.1% | 249.1% | 18,881.3% | 18,881.3% | – | – | – | – | – | – | – | – | 2,044.3% | 2,044.3% | 450.3% | 450.3% | 134.1% | 262.6% | 119.2% | 199.1% | 173.4% | 158.5% | 100.8% | 124.8% | 172.9% | 72.8% | 56.7% | 56.2% | 177.1% | 196.0% | 42.3% | 884.3% | 490.4% | 22.2% | 5,411.3% | 2,290.6% | 3,644.7% | 10,982.4% | 1,667.7% | – | 3,458.5% | |
| 428.7% | 428.7% | 18,881.3% | 18,881.3% | – | – | – | – | – | – | – | – | 3,367.2% | 3,367.2% | 1,338.5% | 1,338.5% | 464.0% | 554.4% | 348.2% | 511.0% | 424.2% | 370.1% | 233.6% | 422.2% | 433.0% | 249.0% | 167.0% | 194.7% | 496.4% | 669.5% | 117.7% | 2,722.9% | 1,830.6% | 106.1% | 20,068.4% | 10,759.8% | 16,565.4% | 36,714.7% | 3,637.7% | – | 10,931.2% | |
| -673.9% | -673.9% | -42,637.5% | -42,637.5% | – | – | – | – | – | – | – | – | -5,338.5% | -5,338.5% | -1,238.5% | -1,238.5% | -481.3% | -515.4% | -297.1% | -478.6% | -389.2% | -329.9% | -173.4% | -386.7% | -404.1% | -230.0% | -106.8% | -125.8% | -453.9% | -633.6% | -35.6% | -3,064.0% | -1,973.5% | -12.7% | -20,006.4% | -10,697.8% | -16,505.7% | -36,650.0% | -3,565.4% | – | -10,880.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.0% | 5.1% | 16.9% | 8.1% | 2.0% | 2.3% | 6.1% | 18.4% | 1.0% | 0.3% | 7.6% | 9.8% | 0.3% | 44.2% | 0.1% | 30.6% | 753.2% | 47.5% | 6,284.3% | – | – | – | – | – | – | |
| -626.0% | -626.0% | -41,600.0% | -41,600.0% | – | – | – | – | – | – | – | – | -5,439.3% | -5,439.3% | -761.7% | -761.7% | -479.9% | -499.3% | -313.9% | -470.5% | -381.9% | -328.9% | -167.3% | -368.4% | -276.7% | -315.8% | -111.4% | -131.9% | -381.0% | -713.0% | -13.2% | -2,916.6% | -2,640.8% | 97.6% | -20,091.6% | -12,207.1% | -13,180.5% | -34,617.6% | -3,544.3% | – | -9,758.9% | |
| -144.5% | -144.5% | -7,125.0% | -7,125.0% | – | – | – | – | – | – | – | – | -778.7% | -778.7% | 200.7% | 200.7% | -23.2% | 31.2% | -46.1% | -40.0% | -67.3% | -52.5% | -33.0% | -40.7% | -65.9% | -27.0% | -21.7% | -17.7% | -86.2% | -26.4% | 1.6% | -314.2% | -275.5% | 39.3% | 5,205.1% | 4.5% | 0.6% | -2.9% | – | – | – | |
| -481.4% | -481.4% | -34,475.0% | -34,475.0% | – | – | – | – | – | – | – | – | -4,660.7% | -4,660.7% | -962.4% | -962.4% | -456.6% | -530.5% | -267.8% | -430.5% | -314.6% | -276.3% | -134.3% | -327.7% | -210.7% | -288.8% | -89.7% | -114.2% | -294.9% | -686.6% | -14.7% | -2,602.3% | -2,365.3% | 58.3% | -20,091.6% | -12,211.6% | -13,181.1% | -34,617.6% | -3,544.3% | – | -9,759.2% | |
| -651.8% | -651.8% | -41,400.0% | -41,400.0% | – | – | – | – | – | – | – | – | -5,285.7% | -5,207.0% | -1,219.8% | -1,219.8% | -469.1% | -307.9% | -293.0% | -465.9% | -376.4% | -329.2% | -165.3% | -365.2% | -272.3% | -312.6% | -102.7% | -120.8% | -376.3% | -710.2% | -18.7% | -2,866.1% | -1,877.5% | 29.6% | -19,994.5% | -10,040.6% | -13,082.4% | -34,285.3% | -3,519.2% | – | -9,814.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.